Table 2.
Baseline Characteristics for SF-6D and EQ-5D Samples by Study
| SF-6D Sample | EQ-5D Sample | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline Characteristics |
Over all |
OPUS | OPTIMAL | CARE | COLPO | Within SF-6D P- value1 |
Overall | OPUS | OPTIMAL | Within EQ-5D P- value1 |
| N | 1,100 | 389 | 309 | 284 | 118 | 715 | 410 | 305 | ||
| Age (mean +/− SD) | 62.9(11.5) | 63.6(10.0) | 57.2(10.9) | 61.6(10.3) | 78.1(5.4) | <0.01 | 61.2(10.7) | 63.8(9.9) | 57.7(10.8) | <0.01 |
| Race | <0.01 | 0.94 | ||||||||
| White | 89% | 88% | 87% | 94% | 91% | 87% | 87% | 87% | ||
| Black | 6% | 6% | 5% | 5% | 8% | 6% | 6% | 6% | ||
| Other Race | 5% | 6% | 7% | 1% | 1% | 7% | 7% | 7% | ||
| Ethnicity (%) | <0.01 | 0.03 | ||||||||
| Hispanic | 11% | 12% | 20% | 3% | 1% | 15% | 12% | 18% | ||
| Non-Hispanic | 89% | 88% | 80% | 97% | 99% | 85% | 88% | 82% | ||
| Baseline Prolapse Stage (%) | <0.01 | <0.01 | ||||||||
| Stage 2 | 25% | 28% | 38% | 13% | 2% | 32% | 28% | 38% | ||
| Stage 3 | 63% | 63% | 57% | 69% | 64% | 61% | 63% | 57% | ||
| Stage 4 | 13% | 9% | 5% | 18% | 34% | 7% | 9% | 5% | ||
| Prior Surgery for Prolapse (%) | 19% | 14% | 6% | 38% | 24% | <0.01 | 11% | 14% | 8% | <0.01 |
| Prior Surgery for Urinary Incontinence (%) | 5% | 3% | 4% | 7% | 14% | <0.01 | 3% | 2% | 4% | 0.18 |
| Prior Hysterectomy (%) | 46% | 39% | 26% | 71% | 61% | <0.01 | 34% | 38% | 28% | <0.01 |
P-value comparing studies